Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Daiichi Sankyo
US Army

Generated: August 22, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Which drugs does patent 6,645,961 protect, and when does it expire?

Patent ► Subscribe protects CRIXIVAN and is included in one NDA.

Summary for Patent: ► Subscribe

Title: Dry granulation formulation for an HIV protease inhibitor
Abstract:This invention relates to a dry granulation capsule formulation of the HIV protease inhibitor, indinavir sulfate, which is useful in the treatment of AIDS, ARC or HIV infection. Processes for making the oral formulation are also disclosed.
Inventor(s): Lui; Chung Y. (Lansdale, PA), Ostovic; Drazen (Lansdale, PA), Katdare; Ashok V. (Norristown, PA), Stelmach; Christine (Tinton Falls, NJ)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Application Number:09/045,885
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Formulation; Process;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Merck Sharp Dohme
indinavir sulfate
CAPSULE;ORAL020685-006Apr 19, 2000DISCNNoNo► Subscribe► SubscribeY
Merck Sharp Dohme
indinavir sulfate
CAPSULE;ORAL020685-003Mar 13, 1996RXYesNo► Subscribe► SubscribeY
Merck Sharp Dohme
indinavir sulfate
CAPSULE;ORAL020685-005Dec 17, 1998DISCNNoNo► Subscribe► SubscribeY
Merck Sharp Dohme
indinavir sulfate
CAPSULE;ORAL020685-001Mar 13, 1996RXYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Fish and Richardson
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus